1369430-91-0

Basic information

• Product Name: C₄₇H₆₅N₃O₁₃
• Synonyms: C₄₇H₆₅N₃O₁₃
• CAS NO: 1369430-91-0
• Molecular Weight: 880.045
• Mol File: 1369430-91-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₄₇H₆₅N₃O₁₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₇H₆₅N₃O₁₃(1369430-91-0)
• EPA Substance Registry System: C₄₇H₆₅N₃O₁₃(1369430-91-0)

Safety Data

• Hazardous Substances Data: 1369430-91-0(Hazardous Substances Data)

Upstream product

• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 16606-30-7 2,4-dibromo-5-isopropylphenol 
• 24078-12-4 4-bromo-2-methylbenzaldehyde 
• 1240304-51-1 C₃₃H₃₉BrO₁₂ 
• 1240304-46-4 (1S)-1,5-anhydro-1-{5-bromo-4-(propan-2-yl)-2-[(trimethylsilyl)oxy]phenyl}-2,3,4,6-tetrakis-O-(trimethylsilyl)-D-glucitol 
• 1240304-31-7 (1S)-2,3,4,6-tetra-O-acetyl-1-[2-(acetyloxy)-5-[(4-bromo-2-methylphenyl)methyl]-4-(propan-2-yl)phenyl]-1,5-anhydro-D-glucitol 
• 1240304-37-3 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[2-(benzyloxy)-4-(propan-2-yl)phenyl]-D-glucitol 
• 1240304-48-6 C₂₃H₂₉BrO₇ 
• 1240304-44-2 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[5-bromo-2-hydroxy-4-(propan-2-yl)phenyl]-D-glucitol 
• 1240304-42-0 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[2-hydroxy-4-(propan-2-yl)phenyl]-D-glucitol 
• 1359948-56-3 C₄₀H₇₃BrO₉Si₅ 
• 1359948-58-5 C₃₆H₄₃BrO₁₄ 
• 1240304-83-9 C₂₁H₃₃N₃O₅ 
• 1240304-82-8 C₁₆H₂₅N₃O₃ 

Downstream Products

• 1369430-92-1 C₃₇H₅₅N₃O₈ 

Relevant articles and documents

4 -ISOPROPYLPHENYL GLUCITOL COMPOUNDS AS SGLTL INHIBITORS

The present invention provides 4-isopropylphenyl glucitol compounds which have no tendency to accumulate in the body and which inhibit SGLT1 activity to suppress postprandial hyperglycemia (or impaired glucose tolerance) through suppression of glucose absorption in the small intestine, whereby the compounds, for example, can suppress the onset of diabetes and metabolic syndrome or can treat these diseases. A 4-isopropylphenyl glucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: [Chem. 1] wherein R1 represents a hydrogen atom, etc., R2 represents a methyl group, etc., R3 represents a C1-4 alkyl group substituted with an amino group(s), etc., and R4 represents a hydrogen atom, etc.